| Zacks Company Profile for Becton, Dickinson and Company (BDX : NYSE) |
|
|
| |
| • Company Description |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Number of Employees: 74,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $177.27 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 2,737,249 shares |
| Shares Outstanding: 286.61 (millions) |
| Market Capitalization: $50,806.90 (millions) |
| Beta: 0.25 |
| 52 Week High: $251.99 |
| 52 Week Low: $163.33 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3.70% |
-0.57% |
| 12 Week |
-15.32% |
-25.80% |
| Year To Date |
-21.86% |
-26.20% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Thomas E. Polen - Chairman; Chief Executive Officer and President
Christopher J. DelOrefice - Executive Vice President and Chief Financial Offic
William M. Brown - Director
Catherine M. Burzik - Director
Carrie L. Byington - Director
|
|
Peer Information
Becton, Dickinson and Company (ITRJ)
Becton, Dickinson and Company (BRLI.)
Becton, Dickinson and Company (GOGY)
Becton, Dickinson and Company (PSTX.)
Becton, Dickinson and Company (ELGXQ)
Becton, Dickinson and Company (CAH)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 075887109
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
|
|
Share - Related Items
Shares Outstanding: 286.61
Most Recent Split Date: 8.00 (2.00:1)
Beta: 0.25
Market Capitalization: $50,806.90 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 2.35% |
| Current Fiscal Quarter EPS Consensus Estimate: $4.01 |
Indicated Annual Dividend: $4.16 |
| Current Fiscal Year EPS Consensus Estimate: $14.19 |
Payout Ratio: 0.30 |
| Number of Estimates in the Fiscal Year Consensus: 10.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: 9.33% |
Last Dividend Paid: 06/09/2025 - $1.04 |
| Next EPS Report Date: 08/07/25 |
|
|
|
| |
